Azaguanine-8（Cat No.:A000810）is a synthetic analog of guanine, classified as a purine derivative. It is primarily studied for its potential as an antimetabolite, interfering with nucleic acid synthesis and thus impacting cell proliferation. Azaguanine-8 has shown promise in research related to cancer therapy, particularly due to its ability to disrupt the growth of rapidly dividing tumor cells. Additionally, it may serve as a tool in studying purine metabolism and related biochemical pathways. Ongoing investigations aim to explore its therapeutic applications and mechanisms of action in various disease models.
| Catalog Number | A000810 |
| CAS Number | 134-58-7 |
| Synonyms | NSC-749, SF-337, SK 1150 |
| Molecular Formula | C4H4N6O |
| Purity | ≥95% |
| Storage | 3 years -20C powder |
| IUPAC Name | 5-amino-2,6-dihydrotriazolo[4,5-d]pyrimidin-7-one |
| InChI | InChI=1S/C4H4N6O/c5-4-6-2-1(3(11)7-4)8-10-9-2/h(H4,5,6,7,8,9,10,11) |
| InChIKey | LPXQRXLUHJKZIE-UHFFFAOYSA-N |
| SMILES | C12=NNN=C1N=C(NC2=O)N |
